| Primary |
| Hyperthyroidism |
47.4% |
| Basedow's Disease |
37.9% |
| Hypothyroidism |
3.2% |
| Thyrotoxic Crisis |
3.2% |
| Exposure During Pregnancy |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypertension |
1.1% |
| Maternal Exposure During Pregnancy |
1.1% |
| Osteoporosis |
1.1% |
| Prostate Cancer |
1.1% |
| Thyroid Disorder |
1.1% |
| Thyroid Function Test Abnormal |
1.1% |
|
| Vomiting |
14.6% |
| White Blood Cell Count Decreased |
10.4% |
| Drug Ineffective |
6.3% |
| Hepatotoxicity |
6.3% |
| Vasculitis |
6.3% |
| Weight Decreased |
6.3% |
| Yellow Skin |
6.3% |
| Congenital Hypothyroidism |
4.2% |
| Leukocytoclastic Vasculitis |
4.2% |
| Liver Transplant |
4.2% |
| Maternal Drugs Affecting Foetus |
4.2% |
| Necrosis |
4.2% |
| Sepsis |
4.2% |
| Systemic Inflammatory Response Syndrome |
4.2% |
| Vasculitis Necrotising |
4.2% |
| Acute Hepatic Failure |
2.1% |
| Antineutrophil Cytoplasmic Antibody Positive |
2.1% |
| Basedow's Disease |
2.1% |
| Blood Thyroid Stimulating Hormone Decreased |
2.1% |
| Brain Oedema |
2.1% |
|
| Secondary |
| Hyperthyroidism |
24.2% |
| Product Used For Unknown Indication |
15.5% |
| Basedow's Disease |
13.5% |
| Hypertension |
6.7% |
| Thyrotoxic Crisis |
5.2% |
| Angina Pectoris |
4.8% |
| Atrial Fibrillation |
4.4% |
| Cardiac Failure Congestive |
3.6% |
| Hypothyroidism |
2.8% |
| Rash |
2.8% |
| Choriocarcinoma |
2.4% |
| Diabetes Mellitus |
2.4% |
| Prophylaxis |
2.4% |
| Drug Use For Unknown Indication |
1.6% |
| Epilepsy |
1.6% |
| Renal Transplant |
1.6% |
| Asthma |
1.2% |
| Bronchitis |
1.2% |
| Gastric Mucosal Lesion |
1.2% |
| Glioblastoma Multiforme |
1.2% |
|
| Pulmonary Alveolar Haemorrhage |
9.5% |
| Hyperthyroidism |
7.1% |
| Pyrexia |
7.1% |
| Toxic Epidermal Necrolysis |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Cross Sensitivity Reaction |
4.8% |
| Laryngeal Oedema |
4.8% |
| Neonatal Tachycardia |
4.8% |
| Pulmonary Embolism |
4.8% |
| Sinus Bradycardia |
4.8% |
| Stevens-johnson Syndrome |
4.8% |
| Systemic Inflammatory Response Syndrome |
4.8% |
| Thrombocytopenia |
4.8% |
| Thyroid Function Test Abnormal |
4.8% |
| Ventricular Tachycardia |
4.8% |
| Vertigo |
4.8% |
| Agranulocytosis |
2.4% |
| Brain Oedema |
2.4% |
| Cytolytic Hepatitis |
2.4% |
| Deep Vein Thrombosis |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.5% |
| Drug Use For Unknown Indication |
9.3% |
| Hyperthyroidism |
8.5% |
| Hypertension |
7.1% |
| Drug Exposure During Pregnancy |
7.0% |
| Atrial Fibrillation |
4.5% |
| Multiple Sclerosis |
3.9% |
| Cardiac Failure |
3.7% |
| Rheumatoid Arthritis |
2.6% |
| Basedow's Disease |
2.5% |
| Insomnia |
2.4% |
| Thyroid Disorder |
2.4% |
| Contraception |
2.1% |
| Non-small Cell Lung Cancer |
2.1% |
| Constipation |
1.7% |
| Nausea |
1.7% |
| Thyrotoxic Crisis |
1.7% |
| Asthma |
1.5% |
| Back Pain |
1.4% |
| Breast Cancer |
1.4% |
|
| Thyrotoxic Crisis |
18.5% |
| Ventricular Septal Defect |
14.0% |
| Weight Decreased |
7.0% |
| Hypothyroidism |
5.7% |
| Pneumonia |
5.1% |
| Toxic Nodular Goitre |
5.1% |
| Vomiting |
5.1% |
| Face Oedema |
4.5% |
| Nausea |
3.8% |
| Urinary Tract Infection |
3.8% |
| Circulatory Collapse |
3.2% |
| Deep Vein Thrombosis |
3.2% |
| Renal Failure |
3.2% |
| Blood Insulin Decreased |
2.5% |
| Cholelithiasis |
2.5% |
| Dehydration |
2.5% |
| Fatigue |
2.5% |
| Hyperthyroidism |
2.5% |
| Polyarteritis Nodosa |
2.5% |
| Rash |
2.5% |
|
| Interacting |
| Gastrointestinal Stromal Tumour |
50.0% |
| Hyperthyroidism |
50.0% |
|
|
